Upgrade to SI Premium - Free Trial

Oppenheimer Starts Regeneron Pharma (REGN) at Perform

March 17, 2017 1:04 AM
Oppenheimer initiates coverage on Regeneron Pharma (NASDAQ: REGN) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

New Coverage

Next Articles